A diagnostic test kit for the simultaneous detection of SARS-CoV-2 and influenza A and B virus nucleic acids using fluorescence PCR methodology. The kit enables multiplex detection of COVID-19 and influenza in a single assay.
Manufactured by
Coyote Bioscience Co.,Ltd
China
Coyote Bioscience is a high-tech enterprise with 10 years of expertise in biosafety and disease control, specializing in rapid pathogen detection technology. The company develops instruments, reagents, system platforms, and AI-powered solutions, with headquarters in Beijing, R&D center in Silicon Valley, and an 8,000 sqm GMP facility in Jiangsu. Holds 83 domestic and international patents including 22 PCT patents.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Healgen Scientific LLC
United States · 4 relevant products
Igenesis(Shanghai)Co.Ltd.
China · 4 relevant products
Biobase Biotech (Jinan) Co.,Ltd
China · 1 relevant product
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 28 relevant matches
CEPALAB · Brazil
A rapid antigen test for simultaneous detection of influenza and 2019-nCoV (SARS-CoV-2) in clinical samples.
Hecin Scientific, Inc. · China
A multiplex diagnostic test kit for nucleic acid detection of SARS-CoV-2, influenza A, and influenza B. This kit enables molecular diagnosis of multiple respiratory pathogens in clinical samples.
Healgen Scientific LLC · United States
CLIA-waived PCR detection kit for simultaneous identification of SARS-CoV-2 and Influenza A/B using direct fluorescence technology. Enables rapid respiratory pathogen screening in clinical and point-of-care settings with streamlined sample-to-result workflow.
25 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products